TheStemCellInfo.com

 

 

 

 

 

 

 

 

  STEM CELL CONTROVERSY

The status of the human embryo and human embryonic stem cell research is a controversial issue as, with the present state of technology, the creation of a human embryonic stem cell line requires the destruction of a human embryo. Stem cell debates have motivated and reinvigorated the ‘pro-life’ movement whose members have concerned themselves with the rights and status of the embryo as an early-aged human life. They believe that embryonic stem cell research instrumentalizes and violates the sanctity of life and constitutes murder . The fundamental assertion of those who oppose embryonic stem cell research is the belief that human life is inviolable, combined with the opinion that human life begins when a sperm cell fertilizes an egg cell to form a single cell.

Most stem cell researchers use embryos that were created but not used in in vitro fertility treatments to derive new stem cell lines. Most of these embryos are slated to be destroyed, or stored indefinitely. In the United States alone, there have been estimates of at least 400,000 such embryos. This has led some opponents of abortion, such as Senator Orrin Hatch, to support human embryonic stem cell research.

Medical researchers widely submit that stem cell research has the potential to dramatically alter approaches to understanding and treating diseases, and to alleviate suffering. In the future, most medical researchers anticipate being able to use technologies derived from stem cell research to treat a variety of diseases and impairments. Spinal cord injuries and Parkinson's disease are two examples that have been championed by high-profile media personalities (i.e. Christopher Reeve and Michael J. Fox). The anticipated medical benefits of stem cell research have added a certain amount of emotion and urgency to the debates, which has been exploited by proponents of embryonic stem cell research.

Recently, researchers at Advanced Cell Technology of Worcester, Mass., succeeded in obtaining stem cells from mouse embryos without killing them (see "[Lanza] technique", below).  If this technique and its reliability are improved, it would alleviate many of the ethical problems related to embryonic stem cell research.


 Arguments for cell research state these reasons:
(1) The utilitarianism argument

The benefits of stem cell research outweigh the cost in terms of embryonic "life"

Embryonic stem cells have the capacity to grow indefinitely in a laboratory environment and can differentiate into almost all types of bodily tissue. This makes embryonic stem cells an attractive prospect for cellular therapies to treat wide range of diseases.[4]
The social, economic, and personal costs of the diseases that embryonic stem cells have the potential to treat, are far greater than the costs associated with the destruction of embryos.
 

(2) The human potential vs humanity argument

The value of an embryo should not be placed on par with the value of a child or adult

This argument often goes hand-in-hand with the utilitarian argument, and can be presented in several forms:

Embryos, while of value, are not equivalent to human life while they are still incapable of existing outside the womb (i.e. they only have the potential for life).
Approximately 18% of zygotes do not implant after conception.

Thus far more embryos are lost due to chance than are proposed to be used for embryonic stem cell research or treatments.
Blastocysts are a cluster of human cells that have not differentiated into distinct organ tissue, making cells of the inner cell mass no more "human" than a skin cell .
Many scientists believe that homo-sapien life only begins when brainwaves and heartbeats develop, which is during the 9th week of pregnancy, so embryos are not humans.
 

(3) The consequentialism argument

The ends (i.e. new treatments and cures) justify the means (i.e. the destruction of an embryos)

This can be seen as a more extreme view of the utilitarianism argument.

(4) The efficiency argument

If an embryo is going to be destroyed anyway, isn't it more efficient to make practical use of it?

In vitro fertilization (IVF) generates large numbers of unused embryos (i.e. 70,000 in Australia alone)[4]. Many of these thousands of IVF embryos are slated for destruction. Using them for scientific research utilizes a resource that would otherwise be wasted.
While the destruction of human embryos is required to establish a stem cell line, no new embryos have to be destroyed to work with existing stem cell lines. It would be wasteful not to continue to make use of these cell lines as a resource.
Because of the laws, especially those of the United States, women are given the right to abort their pregnancies. What will happen to this unborn children? They will only be discarded. Why not take these embryos, and use them for stem cell research? At least then the embryo can possibly be used to save someone else's life, instead of being lost and forgotten.
 

(5) Arguments for the superiority of embryonic stem cells

Embryonic stem cells can be considered far more useful therapeutically than adult stem cells

This is usually presented as a counter-argument to using adult stem cells as an alternative that doesn't involve embryonic destruction.

Embryonic stems cells make up a significant proportion of a developing embryo, while adult stem cells exist as minor populations within a mature individual (e.g. in every 10,000 cells of the bone marrow, only 10 will be usable stem cells). Thus, embryonic stem cells are likely to be easier to isolate and grow ex vivo than adult stem cells.
Embryonic stem cells divide more rapidly than adult stem cells, potentially making it easier to generate large numbers of cells for therapeutic means. In contrast, adult stem cell might not divide fast enough to offer immediate treatment.
Embryonic stem cells have greater plasticity, allowing them to treat a wider range of diseases.
Adult stem cells from the patient's own body might not be effective in treatment of genetic disorders. Allogeneic embryonic stem cell transplantation (i.e. from a healthy donor) may be more practical in these cases than gene therapy of a patient's own cell.
DNA abnormalities found in adult stem cells that are caused by toxins and sunlight may make them poorly suited for treatment.[4].
Embryonic stem cells have been shown to be effective in treating heart damage in mice.

 Arguments against embryonic stem cell research
(1) Embryos are lives

An embryo contains the potential to form a human or is actually a human, therefore it should be valued as highly as a human life.

Similar arguments are commonly voiced by the pro-life movement to condemn abortion. This opinion is often related to religious doctrine that purports that human life and/or soul start at conception. Based upon this value system, the subsequent argument against embryonic stem cell research is teleological, i.e. life (an embryo) is inherently valuable and cannot be involuntarily destroyed to save another life.

As an extension of this, it is argued that the tendency by some supporters of embryonic stem cell researchers to dismiss the ethical significance of embryo destruction may act to devalue human life. Moreover, it has been argued that "the line at which an embryo becomes a human life remains as arbitrary as ever" .

(2) Exploring alternative therapeutic options

Embryonic stem cells should be abandoned in favour of alternatives, such as those involving adult stem cells.

Adult stem cell and cord blood stem cell research would be able to make greater advances if less money and resources were channeled into embryonic stem cell research.
It is claimed by pro-life supporters that the use of adult stem cells from sources such as umbilical cord blood has consistently produced more promising results than the use of embryonic stem cells. Such claims are disputed by supporters of embryonic stem cell research.
Adult stem cells have already produced therapies, while embryonic stem cells have not.[8] However, it should be acknowledged that scientists have studied adult stem cells for decades, but first isolated human embryonic stem cells only in 1998.[9]
 

(3) Scientific flaws in embryonic stem cell research

Another concern with embryonic stem cell research is the tendency of stem cells from embryos to create tumors. However, proposed treatments will use cells derived from ESCs, not undifferentiated ESCs.

(4) Overstatement of research potential

Scientists have long promised spectacular results from embryonic stem cell research, and this has not yet occurred

This argument is hotly debated on both sides. Those critical of embryonic stem cell research point to a current lack of practical treatments, while supporters argue that advances will come with more time and that breakthroughs cannot be predicted.

Conspicuously, some criticism has even come from researchers themselves. For example, in November 2004, Princeton University president and geneticist Shirley Tilghman said, "Some of the public pronouncements in the field of stem-cell research come close to overpromising at best and delusional fantasizing at worst." Similarly, fertility expert and current president of the British Association for the Advancement of Science, Lord Winston has warned of a public backlash against stem cell research if it fails to deliver on some of the "hype" surrounding potential treatments.


 Stem cells without embryonic destruction
Notably, a fundamental impediment to the widespread acceptance of embryonic stem cell research is the destruction of the embryo. Consequently, some stem cell researchers are working to develop techniques of isolating stem cells that are as potent as embryonic stem cells, but do not require the destruction of a human embryo. Some believe that human somatic cells can be coaxed to "de-differentiate" and revert to an embryonic state. Researchers at Harvard University, led by Kevin Eggan, have attempted to transfer the nucleus of a somatic cell into an existing embryonic stem cell, thus creating a new stem cell line.[15] Another study published in August 2006 also indicates that differentiated cells can be reprogrammed to an embryonic-like state by introducing four specific factors.

Researchers at Advanced Cell Technology, led by Robert Lanza, reported the successful derivation of a stem cell line using a process similar to preimplantation genetic diagnosis, in which a single blastomere is extracted from a blastocyst. It should be noted that this process has not yet demonstrated the ability of donor blastocysts to survive to term as well after blastomere harvesting. Nevertheless, this technique may in future allow for the creation of stem cells without embryonic destruction.

 

INDEX

 

   What is a stem cell?
   Research history and developments
Isolation and in vitro culture
Production of male gametes
Contamination by reagents used in cell culture
Reducing donor-host rejection
Potential method for new cell line derivation

   Stem cell therapies
   Controversy of Embryonic stem cell research
Arguments for cell research state these reasons:
Arguments against embryonic stem cell research
Stem cells without embryonic destruction

   Patents covering human stem cell research
   International policy context
   US policy debate
Origins of policy debate in the U.S.

Congressional response

              References

 

mesothelioma cancer prostate cancer lung cancer skin cancer colon cancer ovarian cancer
cervical cancer pancreatic cancer liver cancer bone cancer thyroid cancer testicular cancer

THEINFOSEEKER.COM

AWARENESSSUPPORT.COM

CONTACT WEBMASTER